Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Patients

TA Takanori Abe
YR Yasuhiro Ryuno
SS Satoshi Saito
TA Tomomi Aoshika
MI Mitsunobu Igari
RH Ryuta Hirai
YK Yu Kumazaki
KK Kyoichi Kaira
HK Hiroshi Kagamu
HI Hironori Ishida
SN Shin-ei Noda
SK Shingo Kato
ask Ask a question
Favorite

We retrospectively analyzed patients with T1N0M0 lung cancer and SPD (i.e., FEV1.0 < 1 L) who were treated by CK-SBRT at our institution. Most of these lung cancer patients were clinically diagnosed because their general condition was too poor to undergo biopsies and pathological confirmation. Clinical diagnoses were determined by multidisciplinary discussions, based on results of multimodal examinations, such as computed tomography (CT), 18F fluorodeoxyglucose-positron emission tomography (FDG-PET) and laboratory tests. Treatments such as surgery or radiation were also discussed by the cancer board. Cancers were staged using CT, FDG-PET and gadolinium-enhanced head magnetic resonance imaging, and classified by the Union for International Cancer Control (UICC) criteria (8th edition). This study was approved by our hospital’s institutional review board (No. 18–132).

Copyright and License information:  ©2020 The Author(s) 2020. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A